Prescription drug · ANDA
Verapamil Hydrochloride NDC 70771-1602
Verapamil hydrochloride 2.5 mg/mL · Injection, Solution · Intravenous · Zydus Lifesciences Limited
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 70771-1602-5 | 7077116020570771160205 | 5 VIAL in 1 CARTON (70771-1602-5) / 4 mL in 1 VIAL (70771-1602-1)Marketed from Oct 22, 2020 |
How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Verapamil Hydrochloride
- Generic name (nonproprietary)
- verapamil hydrochloride
- Active ingredients
- Verapamil hydrochloride — 2.5 mg/mL
- Dosage form
- Injection, Solution
- Route
- Intravenous
- Labeler
- Zydus Lifesciences LimitedNDC labeler code 70771
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214215
- Marketing start
- Listing expires
- Other FDA classes
- Calcium Channel Antagonists (Mechanism)Cytochrome P450 3A Inhibitors (Mechanism)Cytochrome P450 3A4 Inhibitors (Mechanism)P-Glycoprotein Inhibitors (Mechanism)
- Identifiers
- Product ID 70771-1602_f1081c30-3025-42ce-b222-824630689bb8SPL ID f1081c30-3025-42ce-b222-824630689bb8SPL set ID cccf4a5f-6c5d-4d52-97e4-fe7a2dbd28d8RxCUI 898316, 1665057UNII V3888OEY5R
- Pharmacologic class
- Calcium Channel Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N470771160205followed by a unit qualifier and the quantityPackage 70771-1602-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
About NDC 70771-1602
- What is NDC 70771-1602?
- 70771-1602 is the product NDC for Verapamil Hydrochloride, Verapamil hydrochloride 2.5 mg/mL injection, solution, listed with the FDA by Zydus Lifesciences Limited. It has 1 package NDC, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Verapamil Hydrochloride.
- What is the active ingredient?
- Verapamil hydrochloride.
- Who is the labeler?
- Zydus Lifesciences Limited, NDC labeler code 70771. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Verapamil Hydrochloride?
- 131 other product NDCs are listed under this name. See all Verapamil Hydrochloride NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Verapamil Hydrochloride products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Verapamil hydrochloride | Verapamil hydrochloride 120 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1953 | 70771-1953-0170771-1953-05 |
| Verapamil hydrochloride | Verapamil hydrochloride 180 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1954 | 70771-1954-0170771-1954-05 |
| Verapamil hydrochloride | Verapamil hydrochloride 240 mg/1 | TabletOral | Zydus Lifesciences Limited | 70771-1955 | 70771-1955-0170771-1955-05 |
| Verapamil hydrochloride | Verapamil hydrochloride 120 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-561 | 68382-0561-0168382-0561-05 |
| Verapamil hydrochloride | Verapamil hydrochloride 180 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-562 | 68382-0562-0168382-0562-05 |
| Verapamil hydrochloride | Verapamil hydrochloride 240 mg/1 | TabletOral | Zydus Pharmaceuticals (USA) Inc. | 68382-563 | 68382-0563-0168382-0563-05 |
| Verapamil Hydrochloride | Verapamil hydrochloride 120 mg/1 | Capsule, Extended releaseOral | Safecor Health LLC | 48433-145 | 48433-0145-20 |
| Verapamil Hydrochloride | Verapamil hydrochloride 180 mg/1 | TabletOral | REMEDYREPACK INC. | 70518-4513 | 70518-4513-00 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | REMEDYREPACK INC. | 70518-4453 | 70518-4453-00 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | Caplin Steriles Limited | 65145-114 | 65145-0114-05 |
Other NDCs under ANDA 214215
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1643 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1644 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | Zydus Pharmaceuticals USA Inc. | 70710-1937 |
| Verapamil Hydrochloride | Verapamil hydrochloride 2.5 mg/mL | Injection, SolutionIntravenous | Zydus Lifesciences Limited | 70771-1601 |